One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like AVITA Medical Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell AVITA Medical Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding AVITA Medical Inc’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About AVITA Medical Inc (RCEL)

Before we jump into AVITA Medical Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AVITA Medical Inc. is a regenerative medicine company. The Company is focused on the development and commercialization of devices and autologous cellular therapies for skin restoration. It provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its RECELL Autologous Cell Harvesting System enables clinicians to prepare Spray-On Skin Cells, an autologous skin cell suspension, which is sprayed onto the patient to regenerate natural healthy skin. The RECELL System is a single use disposable, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators to achieve the disaggregation and delivery of skin cells. It offers RECELL System technology platform for the treatment of acute thermal burns in both adults and children. The RECELL System is used to prepare Spray-On Skin Cells using patient’s own skin to treat severe burns, while reducing the amount of donor skin required.

Want to learn more about AVITA Medical Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AVITA Medical Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

AVITA Medical Inc’s Stock Price as of Market Close

As of March 27, 2023, 4:00 PM CST, AVITA Medical Inc’s stock price was $13.39.

AVITA Medical Inc is up 4.28% from its previous closing price of $12.84.

During the last market session, AVITA Medical Inc’s stock traded between $12.52 and $12.90. Currently, there are 25.08 million shares of AVITA Medical Inc stock available for purchase.

Unfortunately, AVITA Medical Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

AVITA Medical Inc Stock Price History

AVITA Medical Inc’s (RCEL) price is currently down 0.15% so far this month.

During the month of March, AVITA Medical Inc’s stock price has reached a high of $14.75 and a low of $12.46.

Over the last year, AVITA Medical Inc has hit prices as high as $14.75 and as low as $4.41. Year to date, AVITA Medical Inc’s stock is up 11.77%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AVITA Medical Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 24, 2023, there were 0 analysts who downgraded AVITA Medical Inc’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate AVITA Medical Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

AVITA Medical Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AVITA Medical Inc (RCEL) by visiting AAII Stock Evaluator.

Relative Price Strength of AVITA Medical Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 24, 2023, AVITA Medical Inc has a weighted four-quarter relative price strength of 34.85%, which translates to a Momentum Score of 98 and is considered to be Very Strong.

Want to learn more about how AVITA Medical Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AVITA Medical Inc Stock Price: Bottom Line

As of March 27, 2023, AVITA Medical Inc’s stock price is $13.39, which is up 4.28% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell AVITA Medical Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.